These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 25907200

  • 1. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
    David G, Lim S, Gunnarsson C, Kocharian R, Roy S.
    J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
    [Abstract] [Full Text] [Related]

  • 2. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients.
    Makhija D, Rock M, Ikeme S, Kuntze E, Epstein JD, Nicholson G, Price JS, Patel V.
    J Med Econ; 2017 Jun; 20(6):606-613. PubMed ID: 28287015
    [Abstract] [Full Text] [Related]

  • 3. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures.
    Makhija D, Rock M, Xiong Y, Epstein JD, Arnold MR, Lattouf OM, Calcaterra D.
    J Med Econ; 2017 Jun; 20(6):565-573. PubMed ID: 28097913
    [Abstract] [Full Text] [Related]

  • 4. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery.
    Price JS, Tackett S, Patel V.
    J Med Econ; 2015 Jun; 18(10):777-86. PubMed ID: 25934148
    [Abstract] [Full Text] [Related]

  • 5. Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients.
    Ramirez MG, Niu X, Epstein J, Yang D.
    J Med Econ; 2018 Oct; 21(10):1041-1046. PubMed ID: 30112922
    [Abstract] [Full Text] [Related]

  • 6. Real-world outcomes of hemostatic matrices in cardiac surgery.
    Tackett SM, Calcaterra D, Magee G, Lattouf OM.
    J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):1558-65. PubMed ID: 25245578
    [Abstract] [Full Text] [Related]

  • 7. Floseal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes.
    Ramirez MG, Deutsch H, Khanna N, Cheatem D, Yang D, Kuntze E.
    Hosp Pract (1995); 2018 Oct; 46(4):189-196. PubMed ID: 29986148
    [Abstract] [Full Text] [Related]

  • 8. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
    Mathiasen RA, Cruz RM.
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
    [Abstract] [Full Text] [Related]

  • 9. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
    Hutchinson RW, Werrlein S, Johns DB, Zhang G, Clymer JW, Kocharian R.
    Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
    [Abstract] [Full Text] [Related]

  • 10. Hospital economic impact from hemostatic matrix usage in cardiac surgery.
    Tackett SM, Sugarman R, Kreuwel HT, Alvarez P, Nasso G.
    J Med Econ; 2014 Sep; 17(9):670-6. PubMed ID: 24927164
    [Abstract] [Full Text] [Related]

  • 11. Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal versus Surgiflo.
    Landi A, Gregori F, Marotta N, Delfini R.
    J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):139-43. PubMed ID: 26351870
    [Abstract] [Full Text] [Related]

  • 12. FLOSEAL Versus SURGIFLO in Lumbar Surgery: Similar Outcomes, Different Costs in a Matched Cohort Analysis.
    Ye IB, Thomson AE, Smith RA, Pease TJ, Chowdhury N, Donahue J, Miseo V, Jauregui JJ, Cavanaugh DL, Koh EY, Ludwig SC.
    World Neurosurg; 2023 Jun 24. PubMed ID: 37356481
    [Abstract] [Full Text] [Related]

  • 13. Real-world economic and clinical outcomes associated with current hemostatic matrix use in spinal surgery.
    Danker W, Kelkar SS, Marston XL, Aggarwal J, Johnston SS.
    J Comp Eff Res; 2022 Dec 24; 11(17):1231-1240. PubMed ID: 36306241
    [Abstract] [Full Text] [Related]

  • 14. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures.
    Gazzeri R, Galarza M, Alfier A.
    Surg Technol Int; 2012 Dec 24; 22():49-54. PubMed ID: 22915500
    [Abstract] [Full Text] [Related]

  • 15. Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial.
    Murray S, Mendez A, Hopkins A, El-Hakim H, Jeffery CC, Côté DWJ.
    J Otolaryngol Head Neck Surg; 2018 Jan 08; 47(1):3. PubMed ID: 29310703
    [Abstract] [Full Text] [Related]

  • 16. Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding.
    MacDonald MH, Zhang G, Tasse L, Wang D, De Leon H, Kocharian R.
    J Mater Sci Mater Med; 2021 Sep 30; 32(10):127. PubMed ID: 34591193
    [Abstract] [Full Text] [Related]

  • 17. Gelatin Paste as an Alternative Cost-Effective Hemostatic Agent in Cranial Surgery: Doing More with Less.
    Serrato-Avila JL, Navarro-Fernández JO, Hernández-Reséndiz R, Cacho-Díaz B, Reyes-Soto G, Monroy-Sosa A.
    World Neurosurg; 2019 Feb 30; 122():224-228. PubMed ID: 30415038
    [Abstract] [Full Text] [Related]

  • 18. Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review.
    Echave M, Oyagüez I, Casado MA.
    BMC Surg; 2014 Dec 20; 14():111. PubMed ID: 25528250
    [Abstract] [Full Text] [Related]

  • 19. Perioperative outcomes and hospital costs associated with flowable gelatin hemostatic matrix for lumbar surgeries in real world hospital setting.
    Wu B, Song K, Gong Q, Zhan H, Chen W, Wang Z.
    J Med Econ; 2019 Sep 20; 22(9):917-923. PubMed ID: 31124723
    [Abstract] [Full Text] [Related]

  • 20. Intraoperative anaphylaxis secondary to intraosseous gelatin administration.
    Luhmann SJ, Sucato DJ, Bacharier L, Ellis A, Woerz C.
    J Pediatr Orthop; 2013 Sep 20; 33(5):e58-60. PubMed ID: 23752162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.